Skip to main content
Top
Published in: Archives of Virology 1/2012

01-01-2012 | Brief Report

Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin

Authors: Andrey A. Kolokoltsov, Shramika Adhikary, Jennifer Garver, Lela Johnson, Robert A. Davey, Eric M. Vela

Published in: Archives of Virology | Issue 1/2012

Login to get access

Abstract

Arenaviruses and filoviruses are capable of causing hemorrhagic fever syndrome in humans. Limited therapeutic and/or prophylactic options are available for humans suffering from viral hemorrhagic fever. In this report, we demonstrate that pre-treatment of host cells with the kinase inhibitors genistein and tyrphostin AG1478 leads to inhibition of infection or transduction in cells infected with Ebola virus, Marburg virus, and Lassa virus. In all, the results demonstrate that a kinase inhibitor cocktail consisting of genistein and tyrphostin AG1478 is a broad-spectrum antiviral that may be used as a therapeutic or prophylactic against arenavirus and filovirus hemorrhagic fever.
Literature
1.
go back to reference Towner J, Sealy T, Ksiazek TG, Nichol ST (2007) High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 196:S205–S212PubMedCrossRef Towner J, Sealy T, Ksiazek TG, Nichol ST (2007) High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 196:S205–S212PubMedCrossRef
2.
go back to reference Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ (2010) Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus species. PLoS Pathog 6:e1000904PubMedCrossRef Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ (2010) Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus species. PLoS Pathog 6:e1000904PubMedCrossRef
3.
go back to reference McCormick JB, King I, Webb P, Johnson K, O’Sullivan R, Smith E, Tripple S, Tong T (1986) Lassa fever: effective therapy with Ribavirin. N Engl J Med 314:20–26PubMedCrossRef McCormick JB, King I, Webb P, Johnson K, O’Sullivan R, Smith E, Tripple S, Tong T (1986) Lassa fever: effective therapy with Ribavirin. N Engl J Med 314:20–26PubMedCrossRef
4.
go back to reference Akula S, Hurley D, Wixon R, Wang C, Chase C (2002) Effect of genistein on replication of bovine herpes virus type 1. Am J Veter Res 63:1124–1128CrossRef Akula S, Hurley D, Wixon R, Wang C, Chase C (2002) Effect of genistein on replication of bovine herpes virus type 1. Am J Veter Res 63:1124–1128CrossRef
5.
go back to reference Andres A, Donovan SM, Kuhlenschmidt TB, Kuhlenschmidt MS (2007) Isoflavones at concentrations present in soy infant formula inhibit Rotavirus infection in vitro. J Nutr 137(9):2068–2073 Andres A, Donovan SM, Kuhlenschmidt TB, Kuhlenschmidt MS (2007) Isoflavones at concentrations present in soy infant formula inhibit Rotavirus infection in vitro. J Nutr 137(9):2068–2073
6.
go back to reference Lecot S, Belouzard S, Dubuisson J, Rouille Y (2005) Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis. J Virol 79:10826–10829PubMedCrossRef Lecot S, Belouzard S, Dubuisson J, Rouille Y (2005) Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis. J Virol 79:10826–10829PubMedCrossRef
7.
go back to reference Yura Y, Yoshida H, Sato M (1993) Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch Virol 132:451–461PubMedCrossRef Yura Y, Yoshida H, Sato M (1993) Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch Virol 132:451–461PubMedCrossRef
8.
go back to reference Vela EM, Colpitts T, Zhang L, Davey R, Aronson J (2008) Pichindé virus is trafficked through a dynamin 2 endocytic pathway that is dependent on cellular Rab5- and Rab7-mediated endosomes. Arch Virol 153:1391–1396PubMedCrossRef Vela EM, Colpitts T, Zhang L, Davey R, Aronson J (2008) Pichindé virus is trafficked through a dynamin 2 endocytic pathway that is dependent on cellular Rab5- and Rab7-mediated endosomes. Arch Virol 153:1391–1396PubMedCrossRef
9.
go back to reference Vela EM, Knostman KA, Mott JM, Warren RL, Garver JN, Vela LJ, Stammen RL (2010) Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model. Antivir Res 87:318–328PubMedCrossRef Vela EM, Knostman KA, Mott JM, Warren RL, Garver JN, Vela LJ, Stammen RL (2010) Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model. Antivir Res 87:318–328PubMedCrossRef
10.
go back to reference Sbrana E, Mateo RI, Xiao S-Y, Popov VL, Newman PC, Tesh RB (2006) Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. Am J Trop Med Hyg 74:1096–1102PubMed Sbrana E, Mateo RI, Xiao S-Y, Popov VL, Newman PC, Tesh RB (2006) Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. Am J Trop Med Hyg 74:1096–1102PubMed
11.
go back to reference Vela E, Knostman K, Warren R, Garver J, Stammen R (2010) The disease progression associated with Pirital virus infection in the Syrian golden hamster. J Infect Dis Immun 2:15–23 Vela E, Knostman K, Warren R, Garver J, Stammen R (2010) The disease progression associated with Pirital virus infection in the Syrian golden hamster. J Infect Dis Immun 2:15–23
12.
go back to reference Xiao S-Y, Zhang H, Yang Y, Tesh RB (2001) Pirital virus (Arenaviridae) infection in the Syrian golden hamster, Mesocricetus auratus: a new animal model for arenaviral hemorrhagic fever. Am J Trop Med Hyg 64:111–118PubMed Xiao S-Y, Zhang H, Yang Y, Tesh RB (2001) Pirital virus (Arenaviridae) infection in the Syrian golden hamster, Mesocricetus auratus: a new animal model for arenaviral hemorrhagic fever. Am J Trop Med Hyg 64:111–118PubMed
13.
go back to reference Han Y, Caday CG, Nanda A, Cavenee WK, Huang H-JS (1996) Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res 56:3859–3861PubMed Han Y, Caday CG, Nanda A, Cavenee WK, Huang H-JS (1996) Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res 56:3859–3861PubMed
14.
go back to reference Vela EM, Bowick GC, Herzog NK, Aronson JF (2008) Genistein treatment of cells inhibits arenavirus infection. Antivir Res 77:153–156PubMedCrossRef Vela EM, Bowick GC, Herzog NK, Aronson JF (2008) Genistein treatment of cells inhibits arenavirus infection. Antivir Res 77:153–156PubMedCrossRef
15.
go back to reference Smit JM, Bittman R, Wilschut J (1999) Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol 73:8476–8484PubMed Smit JM, Bittman R, Wilschut J (1999) Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol 73:8476–8484PubMed
16.
go back to reference Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:2002–2007CrossRef Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:2002–2007CrossRef
17.
go back to reference Bowick G, Fennewald S, Scott E, Zhang L, Elsom B, Aronson J, Spratt H, Luxon B, Gorenstein D, Herzog N (2007) Identification of differentially activated cell-signalling networks associated with Pichinde virus pathogenesis by using systems kinomics. J Virol 81:1923–1933PubMedCrossRef Bowick G, Fennewald S, Scott E, Zhang L, Elsom B, Aronson J, Spratt H, Luxon B, Gorenstein D, Herzog N (2007) Identification of differentially activated cell-signalling networks associated with Pichinde virus pathogenesis by using systems kinomics. J Virol 81:1923–1933PubMedCrossRef
18.
go back to reference Radoshitzky S, Abraham J, Spiropoulou C, Kuhn J, Nguyen D, Wenhui L, Nagel J, Schmidt P, Nunberg J, Andrews N, Farzan M, Choe H (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92–96PubMedCrossRef Radoshitzky S, Abraham J, Spiropoulou C, Kuhn J, Nguyen D, Wenhui L, Nagel J, Schmidt P, Nunberg J, Andrews N, Farzan M, Choe H (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92–96PubMedCrossRef
19.
go back to reference Martinez M, Cordo S, Candurra N (2007) Characterization of Junin arenavirus cell entry. J Gen Virol 88:1776–1784PubMedCrossRef Martinez M, Cordo S, Candurra N (2007) Characterization of Junin arenavirus cell entry. J Gen Virol 88:1776–1784PubMedCrossRef
20.
go back to reference Vela E, Zhang L, Colpitts T, Davey R, Aronson J (2007) Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 369:1–11PubMedCrossRef Vela E, Zhang L, Colpitts T, Davey R, Aronson J (2007) Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 369:1–11PubMedCrossRef
21.
go back to reference Castilla V, Merisch S (1996) Low pH-induced fusion of Vero cells infected with Junin virus. Arch Virol 141:1307–1317PubMedCrossRef Castilla V, Merisch S (1996) Low pH-induced fusion of Vero cells infected with Junin virus. Arch Virol 141:1307–1317PubMedCrossRef
22.
go back to reference Di Simone C, Zandonatti M, Buchmeier M (1994) Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology 198:455–465PubMedCrossRef Di Simone C, Zandonatti M, Buchmeier M (1994) Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology 198:455–465PubMedCrossRef
23.
go back to reference Di Simone C, Buchmeier M (1995) Kinetics and pH dependence of acid-induced structural changes in the lymphoytic choriomeningitis virus glycoprotein complex. Virology 209:3–9PubMedCrossRef Di Simone C, Buchmeier M (1995) Kinetics and pH dependence of acid-induced structural changes in the lymphoytic choriomeningitis virus glycoprotein complex. Virology 209:3–9PubMedCrossRef
24.
go back to reference Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A (1999) Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci 112:1303–1311PubMed Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A (1999) Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci 112:1303–1311PubMed
26.
go back to reference McNiven M, Cao H, Pitts K, Yoon Y (2000) The dynamin family of mechanoenzymes: pinching in new places. TRENDS Biochem Sci 25:115–120PubMedCrossRef McNiven M, Cao H, Pitts K, Yoon Y (2000) The dynamin family of mechanoenzymes: pinching in new places. TRENDS Biochem Sci 25:115–120PubMedCrossRef
27.
go back to reference Ang F, Wong A, Ng M, Chu J (2010) Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J 7:24PubMedCrossRef Ang F, Wong A, Ng M, Chu J (2010) Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J 7:24PubMedCrossRef
28.
go back to reference Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ (2010) Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401:18–28PubMedCrossRef Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ (2010) Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401:18–28PubMedCrossRef
29.
go back to reference Jin M, Park J, Lee S, Park B, Shin J, Song KJ, Ahn TI, Hwang SY, Ahn BY, Ahn K (2002) Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294:60–69PubMedCrossRef Jin M, Park J, Lee S, Park B, Shin J, Song KJ, Ahn TI, Hwang SY, Ahn BY, Ahn K (2002) Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294:60–69PubMedCrossRef
30.
go back to reference Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P (2003) Folate receptor alpha and Caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77:13433–13438PubMedCrossRef Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P (2003) Folate receptor alpha and Caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77:13433–13438PubMedCrossRef
Metadata
Title
Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin
Authors
Andrey A. Kolokoltsov
Shramika Adhikary
Jennifer Garver
Lela Johnson
Robert A. Davey
Eric M. Vela
Publication date
01-01-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 1/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-011-1115-8

Other articles of this Issue 1/2012

Archives of Virology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine